Master in Manufacturing of ATMPs

OVERVIEW

The International Society for Cell & Gene Therapy (ISCT) is proud to provide partial scholarships (coverage: 50%) for a total of 4 ISCT European Members to enroll in the 2025/2026 Master’s Degree or Specialization Degree in Manufacturing of Advanced Therapy Medicinal Products, offered by the University of Granada / Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT).

The Master and Specialization degree programs are operated by a partnership between ANd&tAT and the University of Granada with scholarship funding from the ISCT Institute of Training & Development. The 2025/2026 is the third iteration of the scholarship program supported by ISCT. 

View Program Brochure

View Sponsor Prospectus

COURSE CONTENT
  • Both Master's and Specialization degrees will include 12 online modules for students to complete at their pace between Feb 2025-April 2026, with online discussions and activities to promote engagement as well as continuous support from instructors and professors through the course.

  • Master Degree will also include a 3-week practical GMP lab training at Línea IAVANTE’s (Fundación Progreso y Salud) in Granada, Spain for scholars to gain hands-on technical expertise necessary to manufacture ATMPs for clinical use. 
TUITION COST
  • Specialization Degree in Manufacturing of Advanced Therapy Medicinal Products: €4,500/person
  • Master Degree in Manufacturing of Advanced Therapy Medicinal Products: €8,500/person

SCHOLARSHIP ALLOCATION
  • Two ISCT European Members towards Specialization Degree in Manufacturing of Advanced Therapy Medicinal Products: Each selected scholar will receive 50% tuition scholarship subsidy from ISCT
  • Two ISCT European Members towards Master Degree in Manufacturing of Advanced Therapy Medicinal Products: Each selected scholar will receive 50% tuition scholar subsidy from ISCT

Note: The remaining balance will be the selected scholar's responsibility. Tuition does not cover travel expenses and accommodation for the Master degree program.

DESIGNED FOR: 
  • Professionals presently working or intending to work in Good Manufacturing Practice (GMP)-compliant facilities producing cell therapy, gene therapy, or tissue engineered products for human use. 
  • Professionals who will develop Advanced Therapy Medicinal Products (ATMPs) in different laboratories and institutions (hospitals, academia, or industry) within Europe.

STRUCTURE:
  • Master Degree in Manufacturing of ATMPs
  • Specialization Degree in Manufacturing of ATMPs

ELIGIBILITY REQUIREMENTS:

Applicants must:

  • Reside in Europe
  • Hold an active ISCT membership, and maintain it throughout the duration of the Master/Specialization program
  • Meet the requirements/student profile as outlined in Section 2 of the Master Program 2025/2026 brochure
CONTACT US

    If you need help with registration or have questions, please contact us.

    Contact

    SCHOLARSHIP APPLICATION INSTRUCTIONS & CRITERIA (SCHOLARSHIP APPLICATION NOW CLOSED)

    To apply, please submit the following (3) items:

    • A 1-2 page letter of application (maximum 1,000 words, Arial, font size 10). The letter should provide the applicant’s background, training, interest/ experience in cell and gene therapy production, and career goals. Particular attention and weighting will be placed on the applicant’s reasons for attending the programme.
    • A current curriculum vitae (CV), preferably in the NIH Biographical Sketch format.
    • A one-page letter of recommendation.


    Please send your application and attachments to workforcedevelopment@isctglobal.org with subject line: ISCT Scholarship Program for EU Members Applications.


    Download Application Instructions
    2023–2024 SCHOLARS

    Congratulations to the awardees of the inaugural ISCT Europe Master Programme Scholarship on their completion of the 2023–2024 Master in Manufacturing of ATMPs at the University of Granada / Andalusian Network for the design and translation of Advanced Therapies.

    Headshot of Alejandro Barquero

    Roberto Gramignoli

    MSc, PhD
    Specialization as Qualified Person

    Roberto Gramignoli, MSc, PhD
    Karolinska Insitute
    Stockholm Sweden

    Specialization as Qualified Person

    Roberto has over 20 years of experience working in academia, with a primary interest in investigating human liver biology, pathology, and disease. During his career, Roberto has played a prominent role in planning, developing and finalizing all the methodological and regulatory issues to translate cellular therapies into clinics, first in Italy, then in the USA, and now at Karolinska Institute. 

    At the Karolinska Institute, his group is active in translating such new stem cell therapy to the clinic, where for the first time, they can inject primary allogenic stem cells without immunosuppression in support.

    Headshot of Alejandro Barquero

    Carolina Iglesias-Lopez

    MSc, PhD
    Master Degree

    Carolina Iglesias-Lopez, MSc, PhD

    Gene Therapy Advisor
    UCB Biopharma
    Brussels, Belgium

    Specialization as Qualified Person

    Carolina has several years of experience working in academia and the ATMP industry, focusing on ATMP quality, regulatory and clinical development. 

    Upon completing this Master Degree programme, Carolina looks forward to acquiring expertise and knowledge to advise on ATMP manufacturing development to succeed in the marketing authorisation, and exchange quality-related issues with regulatory bodies to address development challenges.

     

    Headshot of Alejandro Barquero

    Han Yu (Selena) Hsieh

    BSc
    Master Degree

    Han Yu (Selena) Hsieh, BSc
    Senior GMP Production Scientist
    Advent Bioservices Ltd
    Cambridge, United Kingdom

    Master Degree

    Selena was educated at the University of California, Berkeley with a bachelor’s in Molecular and Cell Biology. She began her professional career in academia with a focus on iPSC research before moving to industry where she gained almost a decade of experience in ATMP manufacturing across Asia, USA, and the UK. 
      
    Through this Master degree, Selena is looking forward to connecting and learning from professionals in the programme and together bring new therapies for more patients in the future. 

    2021–2022 SCHOLARS

    Headshot of Alejandro Barquero

    Alejandro Barquero

    MPharm, MSc

    Specialization as Qualified Person

    Member Profile

    Alejandro Barquero, MPharm, MSc
    Advent Bioservices Ltd
    Sawston, United Kingdom

    Specialization as Qualified Person

    Alejandro Barquero holds a Master of Pharmacy and an MSc in Advanced Therapies & Biotechnological Innovation. After working in the community pharmacy and research laboratories, he decided to step into the blooming ATMP industry, having a first rewarding experience working in QC for Catapult Cell & Gene Therapy. In 2019 Alejandro joined Advent Bioservices Ltd, biopharmaceutical CDMO specialized in ATMPs, where he has been working as part of the Quality Assurance team ever since.

    At the time of completing this Master Degree programme with a specialization as Qualified Person, Alejandro looks forward to being in the position to meet the statutory requirements to assume a QP role within his organization and help in the development and commercialization of ATMPs.

    Headshot of Miriam López-Parra

    Miriam López-Parra

    MD

    Specialization as Qualified Person

    Member Profile

    Miriam López-Parra, MD
    University Hospital of Salamanca
    Salamanca, Spain

    Specialization as Qualified Person

    Miriam López Parra is a Hematologist and Qualified Person of the GMP Facility of the University Hospital of Salamanca, and researcher at the Institute of Biomedical Research of Salamanca. Miriam is sure this Master will allow her to tackle one of the most important challenges she will have in the coming years, which is the development of a new Cellular Production Unit in her Hospital.

    Headshot of Katja Sirviö

    Katja Sirviö

    MSc (Pharm)

    Specialization as Manufacturing Manager

    Member Profile

    Katja Sirviö, MSc (Pharm)
    Kuopio Center for Gene and Cell Therapy
    Kuopio, Finland

    Specialization as Manufacturing Manager

    Katja Sirviö has 20 years experience working in academic and ATMP industry. She has experience on stem cell research in neurodegenerative diseases at the University of Eastern Finland as well as developing novel cell therapies for solid cancers in Finvector and Kuopio Center for Gene and Cell Therapy.

    The Master in Manufacturing of Advanced Therapy Medicinal Products will provide the essential knowledge for Katja to participate in bringing future therapies to the patients.


    PARTICIPATING ORGANIZATIONS

    This degree program is operated by a partnership of two organizations, the Andalusian Network for the design and translation of Advanced Therapies (ANd&tAT), and the University of Granada, in collaboration with Línea IAVANTE.

    • ISCT Institute of Training & Development: Established in 2023, The ISCT Institute of Training & Development is the first global body dedicated to identifying and addressing critical skills gaps in cell and gene therapy. Leveraging our network of more than 4,000 global ISCT subject matter experts and key opinion leaders from academia, industry, and regulatory sectors, the Institute develops sector-focused, internationally recognized accredited programs. Our programs are governed by the Institute’s Program Advisory Board and Workforce Development Committee to ensure they remain current and in line with the latest developments in the sector.

    • ANd&tAT is an organization affiliated with the Public Healthcare System of Andalusia, and works towards the implementation of cell and gene technologies and theories, including regenerative medicine treatments, within Andalusian public healthcare. ANd&tAT has done significant work to coordinate laboratories, clinical trials, and ATMP use in the region, and offers related training as well as strategic and consultation-based support.

    • The University of Granada is an institution that dates back to 1531, serving over 80,000 students across its programs. Well-respected for the quality of its teaching and research, the university is focused on integrated cooperation and development in society.

    • Línea IAVANTE is an organization affiliated with the Ministry of Health within the Regional Government of Andalusia. Working to facilitate and promote the development and training of health professionals, IAVANTE deploys physical and virtual reality-based simulations that faithfully replicate healthcare environments, including ATMP manufacturing.

    COURSES YOU MAY ALSO BE INTERESTED IN...

    European Advanced Cell Therapy Manufacturing and Regulatory

    The program aims to foster the training of professionals in the fundamentals of ATMP regulations and the specific knowledge necessary for the development of medicinal products for cell therapy, gene therapy, and tissue engineering.

    The Implementation of Cell Counting Standards

    This course will give you a fundamental understanding of cell counting terminology, methods, reporting, processes for cell counts, sample selection, and data analysis.